42586 Federal Register / Vol. 62, No. 152 / Thursday, August 7, 1997 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Advisory Council, Notice of Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), announcement is

made of the following National

Advisory body scheduled to meet

during the month of September 1997.

Name: National Advisory Council on the

National Health Service Corps

Date and Time: September 3–7, 1997

(Times vary).

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, Maryland 20814.

The meeting is open to the public.

Agenda: Agenda items include updates on

the National Health Service Corps program;

meetings with community and clinical

groups on their past experiences with the

NHSC and future partnership development;

academic-community educational linkages;

potential roles for the NHSC; and meetings of

NHSC workgroups on new environment

strategies, health system linkages, and

mission coalition building.

The opening meeting will be held on

Wednesday, September 3 from 6:00 p.m. to

9:00 p.m. On Thursday, Friday, and

Saturday, meetings will begin at 9:00 a.m.

and conclude around 5:00 p.m. Sunday’s

meeting will begin at 8:30 a.m. and adjourn

around 11:00 a.m.

The meeting is open to the public. Anyone

requiring information regarding the subject

Council should contact Ms. Eve Morrow,

National Advisory Council on the National

Health Service Corps, Health Resources and

Services Administration, 8th floor, 4350 East

West Highway, Rockville, Maryland 20857,

Telephone (301) 594–4144.

Agenda Items are subject to change as

priorities dictate.

Dated: August 4, 1997.

James J. Corrigan,

Acting Associate Administrator, Office of

Management and Program Support.

[FR Doc. 97–20874 Filed 8–6–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Institute of Mental

Health Special Emphasis Panel:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: August 14, 1997.

Time: 11 a.m.

Place: Parklawn, Room 9–101, 5600

Fishers Lane, Rockville, MD 20857.

Contact Person: Maureen L. Eister,

Parklawn, Room 9–101, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

3936.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than

fifteen days prior to the meeting due to the

urgent need to meet timing limitations

imposed by the review and funding cycle.

(Catalog of Federal Domestic Assistance

Program Numbers 93.242, 93.281, 93.282)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–20862 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Notice of Meeting of the National

Advisory Research Resources Council

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Advisory Research Resources

Council (NARRC), National Center for

Research Resources (NCRR). This

meeting will be open to the public as

indicated below. Attendance by the

public will be limited to space available.

This meeting will be closed to the

public as indicated below in accordance

with provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, for the

review, discussion and evaluation of

individual grant applications. The

applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with

the applications, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Ms. Maureen Mylander, Public Affairs

Officer, NCRR, National Institutes of

Health, 1 Rockledge Center, Room 5146,

6705 Rockledge Drive, MSC 7965,

Bethesda, Maryland 20892–7965, (301)

435–0888, will provide a summary of

the meeting and a roster of the members

upon request. Other information

pertaining to the meeting can be

obtained from the Executive Secretary

indicated. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact the Executive Secretary in

advance of the meeting.

Name of Committee: The National

Advisory Research Resources Council.

Place of Meeting: Washington Dulles

Hilton Hotel, 13869 Bark Center Road,

Conference Rooms Hilton: East and West,

Herndon, Va.

Open: September 9, 7 p.m.–7:30 p.m.

Agenda: Report of Center Director and

other issues related to Council business.

Closed: September 9, 7:30 p.m.–9:30 p.m.

Open: September 10, 8:30 a.m.–6 p.m.

September 11, 8:30 a.m. until adjournment.

Agenda: Updating the NCRR Stategic Plan.

Executive Secretary: Louise Ramm, Ph.D.,

Deputy Director, National Center for

Research Resources, Building 31, Room

3B11, Bethesda, Md 20892, Telephone: (301)

496–6023.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, Laboratory Animal

Sciences and Primate Research; 93.333,

Clinical Research; 93.337, Biomedical

Research Support; 93.371, Biomedical

Research Technology; 93.389, Research

Centers in Minority Institutions; 93.198,

Biological Models and Materials Research;

93.167, Research Facilities Improvement

Program; 93.214 Extramural Research

Facilities Construction Projects, National

Institutes of Health)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–20859 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meeting:

Name of SEP: Phase II Clinical Trials of

New Chemopreventive Agents.

Date: August 12–13, 1997.

Time: 8 a.m. to 5 p.m.

Place: National Cancer Institute, Executive

Plaza North, Conference Room G, 6130

Executive Boulevard, Bethesda, MD 20892.
Federal Register / Vol. 62, No. 152 / Thursday, August 7, 1997 / Notices 42587

Contact Person: Wilna Woods, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 622B, 6130 Executive Boulevard, MSC

7410, Bethesda, MD 20892–7410, Telephone:

301/496–7903.

Purpose/Agenda: To evaluate and review

responses to Request for Proposal.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Proposals and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institute of Health.

[FR Doc. 97–20857 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Notice of Closed Meeting of the

National Deafness and Other

Communication Disorders Advisory

Council

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Deafness and Other

Communication Disorders Advisory

Council from 1–2 pm on September 11,

1997, in Building 31, Room 3C05,

National Institutes of Health, 9000

Rockville Pike, Bethesda MD 20892. The

meeting will be held as a telephone

conference call.

In accordance with the provisions set

forth in sections 552b(c)(4) and

552b(c)(6), Title 5, United States Code

and section 10(d) of Pub. L. 92–463, the

meeting will be closed to the public.

The meeting will include the review,

discussion, evaluation of individual

grant applications. The applications and

the discussions could reveal

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Further information concerning the

meeting may be obtained from Dr. Craig

A. Jordan, Executive Secretary, National

Deafness and Other Communication

Disorders Advisory Council National

Institute on Deafness and Other

Communication Disorders, National

Institutes of Health, Executive Plaza

South, Room 400C, 6120 Executive

Blvd., MSC7180, Bethesda, Maryland

20892–7180, (301) 496–8693. A

summary of the meeting and rosters of

the members may also be obtained from

his office.

(Catalog of Federal Domestic Assistance

Program No. 93.173 Biological Research

Related to Deafness and Communication

Disorders)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–20858 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

following National Heart, Lung, and

Blood Institute Special Emphasis Panel.

The meeting will be open to the

public to provide concept review of

proposed contract or grant solicitations.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

inform the Contact Person listed below

in advance of the meeting.

Name of Panel: Clinical Trials in Diabetes

and CVD.

Date: September 19, 1997.

Time: 8:00 a.m.

Place: NIH Main Campus, 31 Center Drive,

Building 31, 6th Floor, C Wing, Conference

Room 7.

Agenda: To consider the need for a clinical

trial to determine optimal intervention

strategies to prevent or reduce CVD in

diabetic patients.

Contact Persons:

Peter Savage, M.D., Deputy Director, DECA,

II Rockledge Center, 6701 Rockledge Drive,

MSC 7938, Room 8104, Bethesda,

Maryland 20892–7938, (301) 435–0422.

George Sopko, M.D., Medical Officer, DHVD,

II Rockledge Center, 6701 Rockledge Drive,

MSC 7940, Room 9176, Bethesda, MD

20892–7940, (301) 435–0515.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health.)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–20864 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

following National Heart, Lung, and

Blood Institute Special Emphasis Panel.

The meeting will be open to the

public to provide concept review of

proposed contract or grant solicitations.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

inform the Contact Person listed below

in advance of the meeting.

Name of Panel: New Approaches to

Complex Biological Problems: Inflammation

and Risk Assessment.

Date: September 19, 1997.

Time: 8:00 a.m.

Place: Two Rockledge Center, 6701

Rockledge Drive, Room 7111, Bethesda,

Maryland 20892.

Agenda: To consider the approach and

need for additional research to improve

understanding of the pathogenesis of

inflammation in the lung and clinical risk

assessment related to it by use of non-linear

mathematical techniques.

Contact Person: Hannah H. Peavy, M.D.,

NHLBI/DLD Lung Biology and Disease

Program, Two Rockledge Center, Room

10110, 6701 Rockledge Drive, MSC 7952,

Bethesda, Maryland 20892, (301) 435–0222.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committtee Management Officer, NIH.

[FR Doc. 97–20865 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M